ERNESTINA MELICOFF-PORTILLO to Transplant Recipients
This is a "connection" page, showing publications ERNESTINA MELICOFF-PORTILLO has written about Transplant Recipients.
Connection Strength
0.289
-
Cystic fibrosis lung transplant recipients 10 years of age or younger: Predisposing factors for end-stage disease. Pediatr Pulmonol. 2022 06; 57(6):1513-1519.
Score: 0.171
-
CTOTC-08: A multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients. Am J Transplant. 2022 01; 22(1):230-244.
Score: 0.042
-
Remote intervention engagement and outcomes in the Clinical Trials in Organ Transplantation in Children consortium multisite trial. Am J Transplant. 2021 09; 21(9):3112-3122.
Score: 0.040
-
Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study. Am J Transplant. 2019 12; 19(12):3284-3298.
Score: 0.036